PACE – A new technology for better Post Surgery Healing
Sanuwave Health Inc, a company focused to shock wave technology announced that the results of their pre-clinical study for their brand new PACE technology were more than encouraging. PACE stands for Pulsed Acoustic Cellular Expression and its a technology that utilizes focused high-energy shock waves in order to reduce the post op tissue damage and inflammation that happens while the blood flow is interrupted.
PACE is among the best options to face the IRI (Ischemia-reperfusion injury). What is IRI? After a microprocedure is completed the treated tissue faces an ischemia event (blood flow is interrupted) which is followed by a restoration of blood flow (reperfusion).. this leads to the release of inflammatory factors that can bring damage to the tissue. The results of the study showed that PACE can reduce the inflammatory factors thus leading to a better protection of treated tissues.
Maria Siemionow, Head of Microsurgical Training at Cleveland Clinic’s Department of Plastic Surgery comments: “I am excited by the preclinical results seen with PACE therapy in ischemia-reperfusion injury,” and adds “If these results hold true in further investigations, such an effect should lead to quicker and more complete tissue healing in a variety of medical and surgical settings. PACE therapy could feasibly be used in everyday clinical practice as a novel and convenient therapeutic strategy for protection of tissues against ischemia-reperfusion related injury after microsurgical procedures.”
“This data suggests that, when administered before and after complicated surgeries, the PACE treatments have an effect in reducing inflammation that leads to tissue damage. Reducing inflammation via PACE treatments could provide benefit to both patients and providers. We intend to explore the use of our technology as an adjunct therapy in complex, surgical procedures.” states Joseph Chiarelli, Sanuwave CEO.
This is great news towards the direction of a safer future of Plastic Surgery and we hope that the Clinical study will confirm the pre-clinical results!